PT1667523E - Composições de vacinas de dna e métodos de utilização - Google Patents

Composições de vacinas de dna e métodos de utilização

Info

Publication number
PT1667523E
PT1667523E PT4784389T PT04784389T PT1667523E PT 1667523 E PT1667523 E PT 1667523E PT 4784389 T PT4784389 T PT 4784389T PT 04784389 T PT04784389 T PT 04784389T PT 1667523 E PT1667523 E PT 1667523E
Authority
PT
Portugal
Prior art keywords
methods
vaccine compositions
dna vaccine
dna
compositions
Prior art date
Application number
PT4784389T
Other languages
English (en)
Portuguese (pt)
Inventor
Opendra Narayan
Zhenqian Liu
Original Assignee
Univ Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas Medical Center filed Critical Univ Kansas Medical Center
Publication of PT1667523E publication Critical patent/PT1667523E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT4784389T 2003-09-16 2004-09-16 Composições de vacinas de dna e métodos de utilização PT1667523E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50319703P 2003-09-16 2003-09-16
US10/941,164 US7488485B2 (en) 2003-09-16 2004-09-15 DNA vaccine compositions and methods of use

Publications (1)

Publication Number Publication Date
PT1667523E true PT1667523E (pt) 2013-02-04

Family

ID=34381064

Family Applications (1)

Application Number Title Priority Date Filing Date
PT4784389T PT1667523E (pt) 2003-09-16 2004-09-16 Composições de vacinas de dna e métodos de utilização

Country Status (13)

Country Link
US (3) US7488485B2 (enExample)
EP (1) EP1667523B1 (enExample)
JP (1) JP4989224B2 (enExample)
AU (1) AU2004273965B2 (enExample)
BR (1) BRPI0414442A (enExample)
CA (1) CA2538840C (enExample)
DK (1) DK1667523T3 (enExample)
ES (1) ES2399875T3 (enExample)
IL (1) IL174325A (enExample)
NZ (1) NZ545954A (enExample)
PL (1) PL1667523T3 (enExample)
PT (1) PT1667523E (enExample)
WO (1) WO2005027844A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488485B2 (en) * 2003-09-16 2009-02-10 University Of Kansas Medical Center DNA vaccine compositions and methods of use
US8765140B2 (en) * 2003-09-16 2014-07-01 University Of Kansas Medical Center DNA vaccine compositions with HIV/SIV gene modifications
PT1880008E (pt) * 2005-05-03 2015-08-27 Inserm Inst Nat De La Santé Et De La Rech Médicale Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada
US7585675B2 (en) * 2005-11-15 2009-09-08 University Of Kansas Medical Center Inhibition of HIV and SHIV replication with antisense interleukin-4
FR2979919B1 (fr) * 2011-09-12 2015-12-11 Centre Nat Rech Scient Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1
WO2013126469A1 (en) * 2012-02-21 2013-08-29 Immunogenetix Therapeutics, Inc. Chimeric dna vaccine compositions and methods of use
CA3145791A1 (en) 2019-07-16 2021-01-21 Gilead Sciences, Inc. Hiv vaccines and methods of making and using
KR20230131481A (ko) 2021-01-14 2023-09-13 길리애드 사이언시즈, 인코포레이티드 Hiv 백신 및 이의 사용 방법
CA3208643A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741492A (en) * 1996-01-23 1998-04-21 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6531123B1 (en) * 1997-05-01 2003-03-11 Lung-Ji Chang Lentiviral vectors
US7488485B2 (en) * 2003-09-16 2009-02-10 University Of Kansas Medical Center DNA vaccine compositions and methods of use
US7122180B2 (en) * 2000-10-23 2006-10-17 Children's Medical Center Corporation DNA vectors containing mutated HIV proviruses

Also Published As

Publication number Publication date
EP1667523B1 (en) 2012-11-21
US8916174B2 (en) 2014-12-23
US20090233857A1 (en) 2009-09-17
AU2004273965A1 (en) 2005-03-31
AU2004273965B2 (en) 2010-12-09
JP2007505923A (ja) 2007-03-15
WO2005027844A3 (en) 2005-10-06
JP4989224B2 (ja) 2012-08-01
ES2399875T3 (es) 2013-04-04
DK1667523T3 (da) 2013-01-21
EP1667523A2 (en) 2006-06-14
WO2005027844A2 (en) 2005-03-31
US8003113B2 (en) 2011-08-23
US20120207782A1 (en) 2012-08-16
PL1667523T3 (pl) 2013-05-31
CA2538840A1 (en) 2005-03-31
NZ545954A (en) 2009-04-30
IL174325A (en) 2015-07-30
US20050112102A1 (en) 2005-05-26
EP1667523A4 (en) 2007-12-19
CA2538840C (en) 2014-02-18
IL174325A0 (en) 2008-04-13
BRPI0414442A (pt) 2006-11-14
US7488485B2 (en) 2009-02-10

Similar Documents

Publication Publication Date Title
SG2009050212A (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
AU2003259735A8 (en) Small-mer compositions and methods of use
AU2003239129A8 (en) Methods and compositions for dna manipulation
IL182734A0 (en) 4-aminotetracyclines and methods of use thereof
IL219406A0 (en) Antiloading compositions and methods of selecting same
GB0411940D0 (en) Methods and compositions
IL172647A0 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
AU2003299441A8 (en) Nf-hev compositions and methods of use
TWI339662B (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
GB0303609D0 (en) Novel therapeutic method and compositions
IL174325A0 (en) Dna vaccine compositions and methods of use
PT1667693E (pt) Composições e métodos para usar corpos lamelares com fins terapêuticos
EP1583557A4 (en) VACCINE COMPOSITIONS AND METHODS
GB0324523D0 (en) Compositions and methods of treatment
IL180195A0 (en) Aequorin-containing compositions and methods of using same
IL175746A0 (en) Oral formulations of desoxypeganine and uses thereof
GB0327050D0 (en) Therapeutic methods compositions and uses
GB0303600D0 (en) Novel therapeutic method and compositions
AU2003300770A8 (en) Cardiolipin compositions their methods of preparation and use
HK1087433A (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
PL1667693T3 (pl) Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych
GB0300455D0 (en) Meyhod of vaccine preparation
GB0303165D0 (en) Therapeutic methods and compositions for use therein
GB0302801D0 (en) Therapeutic methods and compositions for use therein